The global landscape for breast cancer diagnostics is undergoing a fundamental shift from volume-based testing to value-based precision diagnostics. According to the latest strategic analysis by Fact.MR, the market, valued at USD 5,878 million in 2025, is poised to reach USD 6,389.41 million in 2026. This trajectory is set to continue at a steady 6.9% CAGR, propelling the industry to a...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek